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Kampa J, Ståhl K, Moreno-López J, Chanlun A, Aiumlamai S, Alenius S: BVDV
and BHV.1 infections in dairy herds in northern and northeastern Thailand. Acta
vet. scand. 2004, 45, 181-192. – Bulk milk samples from 220 dairy herds were collected
at 9 public milk collection centres in the northeastern and northern Thailand, and a sub-
set of 11 herds was selected for individual testing. The samples were tested for presence
of antibodies to BVDV and BHV-1 using an indirect ELISA. The results from the bulk
milk testing demonstrated a moderate level of exposure to BVDV and BHV-1 (73% and
67%, respectively). However, the low proportion of herds with high BVDV antibody-
levels (13%) and the low within-herd seroprevalence of BVDV and BHV-1 in the 11
herds (24% and 5%, respectively), particularly among the young stock (15% and 0%,
respectively), demonstrated a low prevalence of active BVDV infection and a low rate
of reactivation of latent BHV-1. The presence of a self-clearance process was also indi-
cated by the results from the individual testing. Moreover, a surprisingly low prevalence
of BVDV and BHV-1 antibody-positive herds at one of the milk centres was found. This
centre was established 5-10 years before the others. Our impression is that this reﬂects
the self-clearance process, where consecutive replacement of imported infected animals
without further spread has resulted in a nearly total elimination of the infections. 
Based on our experiences and on these results we are convinced that this process can
continue if there is awareness of herd biosecurity. This is especially important in the
context of a future intensiﬁcation of the dairy production. 
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Introduction
Bovine viral diarrhoea virus (BVDV) and
bovine herpesvirus type 1 (BHV-1) are well-
known, important pathogens of cattle that give
rise to substantial economic losses due to re-
productive failures and increased calf mortality,
as well as enteric and respiratory disease. These
pathogens have a worldwide distribution and
tend to be endemic in most populations, al-
though national and regional variations occur
(for BVDV review see Nettleton & Entrican
1995, Houe 1999, Lindberg 2003; for BHV-1
review see Gibbs & Rweywmamu 1977, Kahrs
2001, Straub 2001). 
Vaccination has been the conventional way to
control or reduce losses caused by BVDV and
BHV-1 for the last 4-5 decades (Brock 2004,
Kahrs 2001). The number of licensed vaccines
on the market is vast and they are widely used.
The use of vaccines may reduce economic
losses caused by clinical disease, but does not
appear to result in reduction of the prevalence
of either BVDV or BHV-1 infections (vanOirschot et al. 1996, O´Rourke 2002). The in-
troduction of gene-deleted vaccines was con-
sidered a breakthrough for the control of
BHV-1 (Straub 2001). During 1998-1999 a live
attenuated gE-deleted marker vaccine provided
the basis for a compulsory control programme
in the Netherlands. However, a severe outbreak
of BVDV type 2 on several dairy farms, in-
duced by contaminated gE-deleted marker vac-
cine, was a drawback that illustrated the poten-
tial risks with the use of live vaccines (Barkema
et al. 2001). During the last decades eradication
programmes against BVDV and BHV-1, with-
out the use of vaccines, have been implemented
in some European countries. These have been
based on identiﬁcation and elimination of car-
rier animals, together with increased herd
biosecurity. The national BVD programmes in
the Scandinavian countries, as well as the re-
gional programmes in a few other countries in
Europe, have had success with control of
BVDV and are aiming towards eradication
(Waage et al. 1994, Lindberg & Alenius 1999,
Nuotio et al. 1999, Synge et al. 1999, Bitsch et
al. 2000). Eradication of BHV-1, i.e. ofﬁcial
declaration of freedom by the EU or Efta, has
already been achieved in Switzerland, Norway,
Finland, Denmark, Sweden, Austria and the
province of Bolzano in Italy (Ackermann et al.
1990, SCAHAW 2000). 
Experiences from the Swedish BVDV pro-
gramme have shown that self-clearance, i.e. the
process whereby an infection is eliminated
from a population without intervention, is an
important phenomenon that works in favour of
any BVDV control scheme. Self-clearance oc-
curs when persistently infected (PI) animals are
removed from the herd (due to death, trade or
culling) before they succeed in establishing ad-
ditional persistent infections, and seems to be
more frequent in smaller herds. However,
harder rearing conditions, as might be seen in
larger herds with intensive production, may in-
crease the risk for early death in PI animals and
may consequently increase the probability for
self-clearance (Lindberg & Alenius1999). Self-
clearance has, to our knowledge, not been de-
scribed for BHV-1 infections. During the
Swedish BHV-1 programme, however, reports
on herds changing BHV-1 status from positive
to negative without intervention between con-
secutive samplings, indicated a self-clearing
process. Replacement of animals latently in-
fected with BHV-1 before any reactivation of
latent virus will result in self-clearance as long
as introduced or newborn animals are BHV-1
negative. 
Information on the epidemiology and impact of
BVDV and BHV-1 in developing countries is
limited, even though serological surveys have
been performed in several countries in Asia,
Africa and Latin America (Rweyemamu et al.
1990, Baule et al. 1997, Virakul et al. 1997,
Obando et al. 1999, Ståhl et al. 2002). Given
the assumption that presence of antibodies re-
ﬂects exposure to a pathogen, these surveys
show that BVDV and BHV-1 are widespread.
However, considering the persistence of BVDV
and BHV-1 speciﬁc antibodies and the phe-
nomenon of self-clearance (Kaashoek et al.
1996, Fredriksen et al. 1999, Lindberg & Ale-
nius 1999), serosurveys may give positive re-
sults years after last exposure to virus. 
Dairy production in Thailand dates back to the
1960s when dairy cattle were imported to the
central provinces of the country. The number of
establishments increased rapidly during the fol-
lowing decades to meet the increasing demand.
Since the early 1990s, smallholder dairy farm-
ing has been encouraged in other parts of the
country, including the northeastern and north-
ern provinces. Dairy cattle have been intro-
duced to the new establishments mainly from
the central provinces, but also through imports
from other countries. 
The purpose of this study was to estimate the
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in the northeastern and northern parts of Thai-
land and to study the epidemiological patterns
of the viruses. The purpose was also to estimate
the prevalence of active or recent infection of
BVDV and BHV-1, with the aim to make rec-
ommendations for disease control.
Materials and methods
Study population and survey design
This survey was carried out in 4 provinces in
Thailand, 3 in northeast: Khon Kaen, Udorn
Thani and Sakon Nakorn and one in north: Chi-
ang Mai (see map, ﬁg. 1). The average size of a
dairy herd in the region is 10-20 milking cows,
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Figure 1. Map of Thailand showing the location of the 9 public milk centres from which the bulk milk sam-
ples were collected. The prevalence of BVDV ad BHV-1 seropositive herds among the 220 herds in milk centres
1-7, milk centre 8 and milk centre 9, are shown within diamonds and squares, respectively.with mixed Holstein-Friesian and Sahival
breeds, and with a daily milk production of ap-
proximately 9-11 kg/cow (Department of Live-
stock Development 2002). Most of the produc-
tion in these provinces is commercialised
through public milk collection centres.1
Two hundred and twenty dairy herds were ran-
domly selected from 9 milk centres: 7 located
in the northeastern provinces (milk centres 1-7)
and 2 in one of the northern provinces (milk
centres 8-9). These herds represented approxi-
mately 20% of the dairy herds in the 9 milk cen-
tres (range: 10%-36%). From this set of herds,
a subset of 11 herds located in the Khon Kaen
province (milk centres 1 and 2) was also se-
lected. This selection was based on accessibil-
ity. Vaccination against BVDV or BHV-1 had
not been practised in this part of the country.
Collection of samples
Bulk milk samples from all 220 herds were col-
lected at the public milk collection centres: dur-
ing May to August 2000 in the northeastern
provinces (151 herds) and during January to
June 2001 in the northern (69 herds). A second
sampling was carried out in August 2001 on the
11 selected farms, where individual serum sam-
ples from all animals were collected. All sam-
ples were transported at 4-8°C to the laboratory
on the day of the sampling and centrifuged at
1000 x g. The samples were then inactivated at
56°C for 30 min and stored at -20°C in 2.0 ml
vials until analysed at the Faculty of Veterinary
Medicine and Animal Science, Swedish Uni-
versity of Agricultural Sciences, Uppsala, Swe-
den.
Serological testing and interpretation
Commercial indirect ELISA kits with antigen-
coated microtitre plates were used for detection
of antibodies to BVDV and BHV-1 in bulk milk
and in serum, according to the instructions of
the manufacturer (SVANOVA Biotech AB,
Uppsala, Sweden). The corrected optical den-
sity (COD) level was calculated before inter-
pretation of the results by subtracting the opti-
cal density (OD) for the control antigen from
sample OD (OD sample – OD control = COD).
The Swedish system of classiﬁcation and inter-
pretation of the results of the BVDV antibody
ELISA on bulk milk was used whereby herds
are allocated into 4 different classes based on
COD levels. Herds in classes 0 or 1 (CODs
<0.05 or between 0.05-0.24, respectively) have
a very low or low level of antibodies in the bulk
milk and are unlikely to contain persistently in-
fected animals, unless these have been recently
introduced. Herds in classes 2 or 3 (CODs be-
tween 0.25-0.54 or ≥0.55 respectively) have a
moderate or high level of antibodies. Herds
with active BVDV infection, i.e. herds with PI
animals are most likely to be found among class
3 herds, since the presence of a PI animal in a
herd generally expresses itself as a high degree
of seroconversion in the surrounding animals,
resulting in high levels of antibodies in the bulk
milk and, consequently, high CODs. These
herds will also, in general, have a high sero-
prevalence among the young stock (Lindberg &
Alenius 1999).
The results of the BHV-1 antibody ELISA on
bulk milk were interpreted according to the
Swedish IBR control programme, i.e. samples
with CODs ≥0.05 were considered positive. 
Sera from animals older than 6 months, in total
351 animals, were analysed for presence of an-
tibodies to BVDV and BHV-1. The results were
interpreted according to Juntti et al. (1987), i.e.
sera with CODs ≥0.20 were considered posi-
tive. BHV-1 antibody-positive individuals are
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1 “Milk centre”, when used further on in the text,
refers to the population of herds delivering milk for
commercialisation to a speciﬁc public milk collec-
tion centre.generally considered to be latently infected and
to constitute a potential source of viral trans-
mission (Ackermann et al. 1982). BVDV anti-
body-positive individuals, on the other hand,
have in general recovered from infection and
developed a lifelong immunity (Fredriksen et
al. 1999). Animals persistently infected with
BVDV are in general antibody-negative (Coria
et al. 1972).
A commercial antigen ELISA (Herd Check
BVDV Ag/Serum, Idexx laboratories, INC.)
was used for detection of BVDV antigen in
herds where the presence of PI animals could
be suspected based on the results from the anti-
body ELISA testing. All seronegative animals
older than 6 months and all animals younger
than 6 months were tested in these herds. The
analysis was performed according to the in-
structions of the manufacturer. The corrected
optical density (COD) level was calculated be-
fore interpretation of the results by subtracting
the mean OD for negative controls from sample
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Figure 2. Frequency  distribution of bulk milk corrected optical density (COD) values from the BVDV anti-
body assay (a) with an inserted histogram showing the percentage of herds in each BVDV class derived from the
CODs, for 220 dairy herds in Thailand. (b) The frequency distribution of bulk milk COD from the BHV-1 anti-
body assay.OD (OD sample - meanOD negative = COD). COD
values ≤0.300 were classiﬁed as being negative.
Statistical analysis
The Pearson Chi-square test was used to inves-
tigate a possible association between BVDV
antibody status and BHV-1 status at the herd
level and to analyse differences in prevalences
of BVDV and BHV-1 antibody-positive herds
between regions and between milk centres
within the regions. The differences in mean
bulk milk COD levels between the regions and
between milk centres within the regions were
analysed using the Wilcoxon rank sum-test
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Table 1. Results from BVDV and BHV-1 antibody analysis by indirect ELISA on 220 bulk milk samples col-
lected at 9 public milk centres in northeastern (1-7) and northern (8-9) Thailand, 2000-2001.
Milk centre
1234567 89
Number of herds 11 40 24 20 20 19 17 25 44
No.of BVDV positive* 11 36 22 19 14 17 15 20 6
Prevalence (%) 100 90 92 95 70 90 88 80 14
No.of BHV1 positive* 8 35 22 17 13 10 17 24 1
Prevalence (%) 73 88 92 85 65 53 100 96 2
* Herds with CODs ≥0.05 were considered antibody positive according to the Swedish BVDV and BHV-1 control programmes.
Figure 3. Box plot showing the distribution of bulk milk corrected optical densitiy  (COD) values for BVDV
and BHV-1 from dairy herds in nine public milk centres in Thailand, 2000-2001. Boxes represent the ﬁrst quar-
tile (q1) , median and third quartile (q3) of the COD values from each milk centre, and lower (L) and upper (U)
limits are deﬁned as : L = q1- 1.5x IQR and U = q3+1.5xIQR, where IQR= q3-q1. (Mann-Whitney). On the individual level, the
data was stratiﬁed into 4 categories based on
age, and individual BVDV and BHV-1 sero-
prevalences within each age category were cal-
culated. The Pearson Chi-square test was used
for the analysis. P-values ≤0.05 were consid-
ered statistically signiﬁcant. The statistical soft-
ware, Stata, release 7.0 and 8.0 (StataCorp
2001, College Station, TX, USA) was used for
all statistical analyses.
Results
Bulk milk testing
The distributions of bulk milk COD levels from
BVDV and BHV-1 antibody assays are shown
in ﬁg. 2. The prevalence of BVDV antibody-
positive herds (classes 1, 2 and 3) was 73%
(160/220) and that of BHV-1 67% (147/220).
Sixty-two per cent (136/220) of the herds had
detectable levels of antibodies to both viruses in
the bulk milk. Twenty-nine herds (13%) had
BVDV COD levels above 0.55 and were classi-
ﬁed as class 3 herds. There was a highly signif-
icant relationship between a herd´s BVDV anti-
body status and its BHV-1 status (χ2 =87.5,
p=0.000).
The mean prevalences of BVDV and BHV-1
antibody-positive herds were signiﬁcantly
higher in milk centres 1-7 in the northeastern
provinces (mean prevalences: 89% and 81%,
respectively) than in milk centres 8-9 in the
northern province (mean prevalences: 34% and
36%, respectively; table 1). Milk centre 9 dif-
fered from all the other milk centres, with a
very low prevalence of BVDV and BHV-1 anti-
body-positive herds (ﬁg. 1), and signiﬁcantly
lower mean CODs (ﬁg. 3). Antibodies to
BVDV were detected in bulk milk from 6 out of
44 herds (14%) at milk centre 9, and antibodies
to BHV-1 only in bulk milk from one herd
(2%). 
Individual testing
The results from the individual testing of ani-
mals older than 6 months in the 11 herds are
given in table 2. The within-herd seropreva-
lence of BVDV was low to moderate in all
herds (mean 24%; range: 6%-55%). The
within-herd seroprevalence of BHV-1 was low
in all herds (range: 70%-14%) and in total, only
18 seropositive animals were found. Fifteen out
of these were also seropositive to BVDV. 
All eleven herds were BVDV positive based on
bulk milk testing (mean COD: 0.13; range:
0.05-0.23) and 6 out of 11 were BHV-1 positive
(mean COD: 0.20; range: 0-0.56). The 5 herds
that were BHV-1 negative based on bulk milk
testing were also free from seropositive individ-
uals among the lactating cows (data not shown).
In herd 8, however, 2 seropositive cows were
detected among the non-lactating cows.
The distribution of seropositive animals by age
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Table 2. Results from BVDV and BHV-1 antibody analysis by indirect ELISA on sera from all animals older
than 6 months in 11 dairy herds in the Khon Kaen province, Thailand, 2000-2001.
Herd Total
123456789 1 0 1 1
Number of animals 34 19 37 31 23 26 29 40 41 38 33 351
No. of BVDV positive* 4254382 2 2 1 1 2 028 3
Prevalence (%) 12 11 14 13 13 31 7 55 27 53 6 24**
No. of BHV-1 positive* 225331020001 8
Prevalence (%) 6 11 14 10 13405000 5 * *
* Sera with CODs ≥0.20 were interpreted as seropositive ** i.e.  mean prevalence within the eleven herdsis given in table 3. We found signiﬁcantly
higher seroprevalence of BVDV and BHV-1
among cows older than 6 years (50% and 21%
respectively) compared with that among ani-
mals younger than 6 years (17% and 1% re-
spectively; table 3). The mean age for the BHV-
1 seropositive animals was 8.2 years and none
of the 224 animals between 6 months and 4
years had seroconverted to BHV-1. Only 15 of
the 114 animals below 2 years had serocon-
verted to BVDV and the seroprevalence in this
group was very low in 9 herds (herds 1-7, 9 and
11) and moderate to high in herds 8 and 10
(21% and 64% respectively; data not shown).
No BVDV antigen-positive animals were de-
tected.
Discussion
The results demonstrate a moderate level of ex-
posure to BVDV and BHV-1 in the studied
dairy population with prevalences of antibody-
positive herds of 73% and 67%, respectively.
These prevalences are similar to those reported
previously from northeastern Thailand (Virakul
et al.1997), and do not differ greatly from other
parts of the world (Niskanen et al. 1991, Houe
1995, Paton et al. 1998, Straub 2001). 
The proportion of BVDV class 3 herds was
13%, indicating a low prevalence of active
BVDV infection in the studied population. Re-
sults from previous publications demonstrate
that the proportion of herds potentially having
active BVDV infection shows a wide range of
variation between countries and between re-
gions within countries (Bitsch & Rønsholt
1995, Paton et al. 1998, Nuotio et al. 1999,
Graham et al. 2001, Mainar-Jaime et al. 2001,
Ståhl et al. 2002, Viltrop et al. 2002). This vari-
ation may in part be explained by differences in
demography, such as herd size and population
density, and management factors such as the
pattern and frequency of animal movements
(Houe 1995). 
There was a signiﬁcant association between be-
ing antibody-positive to BVDV and being
BHV-1-positive at the herd level. This corre-
sponds with the results reported by Paton et al.
(1998), suggesting that similar factors affect the
risk of being infected with either virus. One
major risk factor is the introduction of pur-
chased animals with insufﬁcient health docu-
mentation (Valle et al.1999). In this context, we
found the results from milk centre 9 interesting.
The prevalence of BVDV and BHV-1 antibody-
positive herds at milk centre 9 was very low
(14% and 2%, respectively) compared with the
other milk centres and in sharp contrast with
the neighbouring herds at milk centre 8. It was
beyond the scope of this study to explain this
ﬁnding as demography, and management prac-
tices were not studied in detail. However, we
know that most of the herds at milk centre 9
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Table 3. Distribution by age of BVDV and BHV-1 seropositive individuals among animals older than 6 months,
in 11 dairy herds in the Khon Kaen province, Thailand, 2001.
Age No.  of BVDV* BHV-1*
(years) animals No.of positive Prevalence (%) No.of positive Prevalence (%)
> 6 70 35  50 15 21
4-6 57 11 19 3 5
2-4 110 22   20 0 0 
0.5-2 114 15 13 0 0 
Total 351 83 24 18 5
* Sera with CODs ≥0.20 were interpreted as seropositive.were established in the late 1980s, whereas
most of the herds at milk centres 1 to 8 were es-
tablished around 1995. One might thus specu-
late that one reason for the aberrant ﬁnding is
the difference in time that has passed since the
milk centres were established; that the higher
prevalence in the herds at milk centres 1 to 8 to
a large extent represents historical infections
(for BVDV) or latent infections (for BHV-1) in
introduced, i.e. imported, cattle. At milk centre
9, on the other hand, the process has gone fur-
ther and replacement of infected, imported ani-
mals most probably has occurred over the years,
resulting in a nearly total self-clearance of both
BVDV and BHV-1. This hypothesis, however,
needs to be further investigated. 
The selection of the 11 herds used for the indi-
vidual testing was not based on a random pro-
cedure and represents only 2 of the milk
centres. Therefore, these results cannot be gen-
eralised to the entire population. Nevertheless,
they do provide new knowledge on the regional
BVDV and BHV-1 situation. The age distribu-
tion of BVDV seropositive animals in 9 of the
herds clearly demonstrates 2 things: ﬁrstly, ab-
sence of PI animals and secondly that the herds
have been exposed to BVDV in the past. Ac-
cording to our experiences from the Swedish
BVD programme this indicates that self-clear-
ance has occurred. The corresponding results
from herd 8 and especially herd 10, on the other
hand indicated, possible presence of PI animals.
To investigate these ﬁndings and to identify PI
animals, sera from all seronegative cows and
all calves (including calves younger than 6
months) in herds 8 and 10 were analysed by
antigen ELISA, with negative results. It is pos-
sible that PI animals have been present in the
herds recently but that they have died or been
traded before our sampling. But if they suc-
ceeded to transmit the virus to susceptible dams
in early pregnancy, new PI's will be born, and
the infection will be maintained within the
herd. Therefore, these 2 herds should be kept
under surveillance.
The results of the individual testing also sug-
gest an absence of active BHV-1 infection in the
11 herds, with the lack of seroreactors among
cows younger than 4 years. Moreover, we found
evidence that at least 14 out of 18 seropositive
cows had in fact been imported, indicating that
no or very limited virus transmission had oc-
curred following their introduction. This corre-
sponds with the results reported by Pritchard
(1992), suggesting that the risk for reactivation
of latent BHV-1 infections under natural condi-
tions has been overestimated in the past and that
self-clearance may occur. This is probably par-
ticularly true in regions with low-intensive pro-
duction systems, i.e. with low levels of stress to
the animals.
Finally, the results suggest a low rate of reacti-
vation of latent BHV-1 infections and indicate a
progressive self-clearance of BVDV as well as
BHV-1. Based on our experiences from Sweden
and on these results we are convinced that this
process can continue as long as introductions of
infection to non-infected herds are prevented.
Farmers and local authorities must be made
aware of the improvements in animal health
and, thus, on production that can be gained
through the control of these infections. The im-
portance of herd biosecurity must be stressed,
and the information necessary to achieve a suf-
ﬁcient level of biosecurity must be provided.
This is especially important in the context of a
future intensiﬁcation of the dairy production.
We conclude, based on our results, that the
BVDV and BHV-1 situation in the region is
favourable
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Sammanfattning
BVDV och BHV-1 infektioner i mjölkkobesättningar i
norra och nordöstra Thailand.
Tankmjölksprover insamlades från 220 mjölkkobe-
sättningar belägna i 2 regioner i norra respektive
nordöstra Thailand. Insamlingen gjordes vid 9 regio-
nala mjölkinsamlingscentra. Ett urval bestående av
11 besättningar gjordes för individuell provtagning.
Samtliga prover analyserades medelst indirekt
ELISA avseende förekomst av antikroppar mot
BVDV och BHV-1. Resultaten visade en måttlig ex-
poneringsgrad av såväl BVDV som BHV-1 (73% re-
spektive 67%). Den låga förekomsten av besättningar
med höga nivåer BVDV-antikroppar i tankmjölk
(13%) och den låga individuella BVDV- respektive
BHV-1-seroprevalensen bland ungdjur talar dock för
en låg grad av reaktivering av latent BHV-1 och en
låg prevalens av aktiv BVDV-infektion. Resultaten
från den individuella provtagningen indikerar en pro-
gressiv självsanerande process i 9 av de 11 besätt-
ningarna.
Vi fann dessutom en förvånansvärt låg prevalens av
såväl BVDV som BHV-1 bland de besättningar som
tillhörde uppsamlingsområdet för ett av de nio mjöl-
kinsamlingscentra. Dessa besättningar etablerades 5-
10 år tidigare än majoriteten av de övriga besättning-
arna. Vi tror att den nyrekrytering som skett under
årens lopp i dessa besättningar inneburit att importe-
rade infekterade djur ersatts, och att detta resulterat i
en nästintill total självsanering av BVDV och BHV-
1.
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nala situationen avseende BVDV och BHV-1 var
god. Vi fann indikationer på en självsanerande pro-
cess i besättningarna och vi är övertygade om att
denna kommer att fortsätta så länge som man är med-
veten om vikten av en god biosäkerhet. Detta kom-
mer att bli särskilt viktigt vid en framtida intensiﬁer-
ing av mjölkproduktionen i regionen.
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